Immunogenicity of pneumococcal vaccination of patients with cochlear implants

Autor: Ralf Schubert, Stefan Zielen, Markus A. Rose, Volker Gall, Christiane Hey, Sandy Kujumdshiev
Rok vydání: 2003
Předmět:
Zdroj: The Journal of infectious diseases. 190(3)
ISSN: 0022-1899
Popis: Background. Pneumococcal meningitis is a rare but potentially fatal complication of cochlear implantation.Methods. A prospective study was conducted of the immunogenicity of pneumococcal vaccination in 174 patients with cochlear implants (CIs). The cohort was divided into groups of patients with impaired hearing due to meningitis (P 1 ), cranial malformations (P 2 ), or an unknown cause (P 3 ) and was stratified by age as follows: 5 years (A 3 ). We determined immunoglobulin (Ig) levels for IgG subclasses 1–4 and serum concentrations of antibodies against pneumococci before and 4–6 weeks after vaccination. Group A1 received the 7-valent pneumococcal conjugate vaccine (PCV-7), group A 2 received PCV-7 or the 23-valent pneumococcal polysaccharide vaccine (PPV-23), and group A 3 received PPV-23.Results. IgG, IgM, and IgG1 levels were significantly lower in group P 1 , compared with the other patient groups and with historic data for healthy control subjects, suggesting a decreased antibody response. Group P1 had lower levels of pneumococcal antibodies, compared with groups P2 and P3 before vaccination (P
Databáze: OpenAIRE